Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 1 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

CBLI News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

85 Outperform
12 Underperform
 

All-Star Players

8 Outperform
3 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top CBLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Interpol10 (71.07)
Submitted July 20, 2010

If all goes well with CBLI's research, we can hope to see a drug that increases human resistance to radiation. In my opinion, a truly groundbreaking discovery with an obtainable goal in sight, and their first round of testing going well only adds to… More

NetscribeServcs (< 20)
Submitted March 21, 2007

Cleveland Biolabs (CBL) is a biotechnology research and development company, which develops drugs offering protection from radiation and cancer. CBL is engaged in the development of small molecule drugs and biologics focusing on two therapeutic… More

CBLI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CBLI.

Recs

0
Member Avatar AndrewGreenBull (96.16) Submitted: 4/8/2014 10:53:31 AM : Outperform Start Price: $13.80 CBLI Score: -116.79

Should be back to $1 soon

Recs

0
Member Avatar turningpoint84 (42.94) Submitted: 7/22/2013 12:00:53 PM : Outperform Start Price: $33.34 CBLI Score: -142.36

I have a good feeling about them.

Recs

0
Member Avatar JULGABANN (< 20) Submitted: 4/9/2013 5:45:23 PM : Outperform Start Price: $32.00 CBLI Score: -159.56

Cleveland is way undervalued at this point, 2 drug applications for CBLB502 and a BARDA deal on the way... this will double in weeks and be a great buy and hold stock for years to come.

Leaderboard

Find the members with the highest scoring picks in CBLI.

Score Leader

longtermgrowth09

longtermgrowth09 (< 20) Score: +224.43

The Score Leader is the player with the highest score across all their picks in CBLI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
longtermgrowth09 < 20 8/3/2010 Underperform 5Y $74.80 -95.85% +128.58% +224.43 0 Comment
Okcfirefighter < 20 12/17/2010 Underperform 5Y $139.20 -97.77% +106.70% +204.47 0 Comment
thecashmen 46.67 6/5/2012 Underperform 5Y $41.40 -92.50% +101.10% +193.61 1 Comment
jarhead6266 33.97 3/19/2007 Underperform NS $169.40 -98.17% +95.02% +193.19 0 Comment
NetscribeServcs < 20 3/21/2007 Underperform 1Y $178.00 -98.26% +92.64% +190.89 1 Comment
BreakerDc 57.39 3/21/2007 Underperform 3Y $178.20 -98.26% +89.60% +187.86 0 Comment
BetterMoney77 < 20 1/2/2008 Underperform NS $175.80 -98.23% +82.86% +181.09 0 Comment
BigWhereItCounts < 20 7/16/2007 Underperform 3Y $220.00 -98.59% +74.63% +173.22 1 Comment
badpiotroski < 20 6/26/2013 Underperform 5Y $30.60 -89.86% +61.01% +150.86 0 Comment
helicopterfool 97.87 6/25/2015 Underperform 5Y $6.55 -52.62% +22.06% +74.68 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCantorFitz 34.15 3/21/2013 Outperform NS $39.40 -92.12% +66.13% -158.26 0 Comment
TrackOppenheimer 66.44 12/6/2012 Outperform NS $31.00 -56.13% +26.92% -83.05 1/24/2014 @ $13.60 0 Comment
TrackWedbush 84.84 2/2/2011 Outperform NS $139.80 -97.78% +97.17% -194.95 0 Comment
TrackRodmanRen < 20 9/17/2010 Outperform NS $107.20 -97.10% +128.40% -225.50 0 Comment
trackwbbsecuriti < 20 7/21/2010 Outperform NS $66.80 +81.65% +8.43% +73.22 10/13/2010 @ $121.34 0 Comment
TrackZacks < 20 11/17/2008 Outperform 3M $51.40 +28.40% +24.22% +4.19 7/8/2010 @ $66.00 1 Comment
TrackZacks < 20 3/25/2008 Outperform 3M $83.80 -26.49% -26.73% +0.23 10/20/2008 @ $61.60 1 Comment

Featured Broker Partners